BioCentury
ARTICLE | Company News

Galena Biopharma, Mills Pharmaceuticals deal

January 20, 2014 8:00 AM UTC

Galena acquired Mills Pharmaceuticals for about $1.6 million cash up front. Galena gains exclusive, worldwide rights to anagrelide CR ( GALE-401), a controlled-release formulation of generic anti-pla...